P.K. Schädlich
InForMed Gesellschaft für interdisziplinäre Forschung und Beratung im Gesundheitswesen mbH
Hamburg
Germany
Name/email consistency: high
- The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study. Schädlich, P.K., Brecht, J.G. Pharmacoeconomics (1998)
- Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from the perspective of Statutory Health Insurance. Schädlich, P.K., Huppertz, E., Brecht, J.G. Pharmacoeconomics (1998)









